We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Ipilimumab
There is no page with the exact title "Ipilimumab". The search results for "Ipilimumab" are displayed below. You can create a page titled Ipilimumab (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below 15 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Ipilimumab (41 bytes)
1: List of pages with the keyword Ipilimumab
Page text matches
- 8hit (3,461 bytes)
11: ...ng affinity and T-cell activating efficiency over ipilimumab. Moreover, it demonstrates substantial in vivo tu... - 9dq5 (3,795 bytes)
13: ...alent epitope as ipilimumab. These cross-reactive ipilimumab variants may facilitate improved translatability ...
15: Engineered ipilimumab variants that bind human and mouse CTLA-4.,Robiso... - 9dq3 (5,650 bytes)
2: ==Crystal structure of engineered Ipilimumab (mipi.4) Fab in complex with human CTLA-4==
15: ...alent epitope as ipilimumab. These cross-reactive ipilimumab variants may facilitate improved translatability ...
17: Engineered ipilimumab variants that bind human and mouse CTLA-4.,Robiso... - 9dq4 (4,076 bytes)
2: ==Crystal structure of engineered Ipilimumab (mipi.4) Fab in complex with mouse CTLA-4==
14: ...alent epitope as ipilimumab. These cross-reactive ipilimumab variants may facilitate improved translatability ...
16: Engineered ipilimumab variants that bind human and mouse CTLA-4.,Robiso... - 8g8n (4,040 bytes)
11: ...by immune-related adverse events, especially when ipilimumab is used in combination with anti-PD-(L)1 mAb ther... - 5tru (6,253 bytes)
2: ...ucture of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4==
15: ...ants responsible for the selectivity exhibited by ipilimumab toward CTLA-4 relative to the homologous and func...
17: ...herapy by the first-in-class checkpoint inhibitor ipilimumab.,Ramagopal UA, Liu W, Garrett-Thomson SC, Bonanno... - 5xj3 (5,472 bytes)
2: ==Complex structure of ipilimumab-scFv and CTLA-4==
15: ...mparative study of the binding characteristics of ipilimumab and tremelimumab would shed light for the discove...
17: ... similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies.,He M, Chai Y, Qi J, ... - Category:Ipilimumab (41 bytes)
1: List of pages with the keyword Ipilimumab - 6jc2 (1,492 bytes)
2: ==Crystal structure of the Fab fragment of ipilimumab== - 8g2m (4,369 bytes)
12: ...by immune-related adverse events, especially when ipilimumab is used in combination with anti-PD-(L)1 mAb ther... - 6rp8 (1,266 bytes)
2: ==Crystal Structure of Ipilimumab Fab complexed with CTLA-4 at 2.6A resolution== - 7dv4 (3,961 bytes)
12: ...xposure, and more potent anti-tumor activity than ipilimumab in murine tumor models, which is partly driven by... - 7su0 (3,353 bytes)
2: ==Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4==
12: ...ay have a more favorable therapeutic index. While ipilimumab has pH-independent CTLA-4 affinity, pH Ipi varian... - 7su1 (5,428 bytes)
2: ==Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4==
16: ...ay have a more favorable therapeutic index. While ipilimumab has pH-independent CTLA-4 affinity, pH Ipi varian...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
